Azurity Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Azurity Pharmaceuticals brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3355. Its program centres on chronic myeloid leukemia. It hosts a session on a nilotinib treatment option for Ph+ CML in chronic phase.
| Organization | ASH 2026 Attendance |
|---|---|
Azurity Pharmaceuticals Wilmington, MA | |
Specialty pharmaceutical company making dose-form innovations of existing medicines, including oncology drugs, for patients poorly served by standard products. | Booth Exhibiting at Booth 3355 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Talk Sun Dec 13 8:00am–9:00am |
Find decision makers at Azurity Pharmaceuticals
Tell us what you sell and we’ll find the people at Azurity Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction